Key result
Breast cancer is linked to higher cardiovascular mortality versus the general population, peaking at ~10%.
Why the study?
Does breast cancer and its associated treatments increase the risk of cardiovascular disease mortality in women?
Systematic Review (n=4,773,576)
Does breast cancer and its associated treatments increase the risk of cardiovascular disease mortality in women?
Women with breast cancer have an increased risk of cardiovascular mortality compared to the general population, emphasizing the need for targeted cardiovascular risk assessment and prevention in cardio-oncology.
No takes yet. Share an insight, caveat, or question.
Women with breast cancer warrant proactive CV risk assessment and monitoring; confirms elevated mortality versus general population and extends cardio-oncology evidence base.
Gernaat et al. (2017) conducted a systematic review in Breast cancer (n=4,773,576). Breast cancer survivorship vs. General population or different tumor/treatment characteristics was evaluated on Cardiovascular disease mortality. Between 1.6% and 10.4% of women with breast cancer died of cardiovascular disease, representing a higher risk of cardiovascular mortality compared to women from the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: